Current Edition


PATH, SD Biosensor partner to advance malaria treatment

PATH is advancing a portfolio of novel rapid tests for G6PD deficiency that are low cost, simple to use, and meet specifications to improve treatment …

Continue Reading →

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by …

Continue Reading →